Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Assets: 2016-2025

Historic Return on Assets for Tg Therapeutics (TGTX) over the last 9 years, with Sep 2025 value amounting to 0.52%.

  • Tg Therapeutics' Return on Assets rose 55.00% to 0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year increase of 55.00%. This contributed to the annual value of 0.05% for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Tg Therapeutics reported Return on Assets of 0.52% as of Q3 2025, which was up 482.38% from 0.09% recorded in Q2 2025.
  • Over the past 5 years, Tg Therapeutics' Return on Assets peaked at 0.52% during Q3 2025, and registered a low of -1.11% during Q4 2022.
  • In the last 3 years, Tg Therapeutics' Return on Assets had a median value of 0.04% in 2024 and averaged -0.10%.
  • Per our database at Business Quant, Tg Therapeutics' Return on Assets slumped by 42bps in 2022 and then skyrocketed by 122bps in 2024.
  • Over the past 5 years, Tg Therapeutics' Return on Assets (Quarterly) stood at -0.89% in 2021, then declined by 22bps to -1.11% in 2022, then surged by 115bps to 0.04% in 2023, then remained steady at 0.04% in 2024, then spiked by 55bps to 0.52% in 2025.
  • Its Return on Assets was 0.52% in Q3 2025, compared to 0.09% in Q2 2025 and 0.06% in Q1 2025.